Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.
about
DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours.The future of high-grade glioma: Where we are and where are we going.Chemotherapy of anaplastic oligodendroglial tumours.Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: case study.Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131.Response to postoperative radiotherapy as a prognostic factor for patients with low-grade gliomas.Molecular markers of gliomas: a clinical approach.Biomarkers of clinical responsiveness in brain tumor patients : progress and potential.Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma.Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers.Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy.
P2860
Q30542025-E576A519-B029-424E-BFF7-BD65FC7247F4Q35114090-755EDCBD-C2C9-4CDD-BCBC-E35DD0ABB288Q35680586-539FC25F-3042-4220-A647-5BCF8AE8D2AFQ35799829-F002EFB9-5570-4F38-AE51-17A74B51D1F3Q36096036-F83C75A0-BFB4-46B3-9EC7-B71E04DF4501Q36225880-9BFACDB1-F156-4F14-8152-072209610AB3Q36523374-DE377B11-D046-4027-9976-022666BC23FCQ37225840-6033E84E-E5D3-4DAE-A84D-79A6A9ADEFB6Q37284303-4339B40A-1424-4B14-947D-2148BCDF4552Q38623612-636F5417-7C2E-458E-B212-3EB318092FA6Q46720231-CE4A01A9-80C0-4EBE-A0F1-5CC9A1E5811AQ48161996-C2D774D4-1E8B-4041-8015-506E9CA78FBBQ48910170-91FA7C00-E17F-4908-82A0-448C1E8D3942Q50526883-1B3529C7-06A5-4D92-B9DC-9BEDE933626AQ54714055-C9770A14-C9CA-40DC-B65B-22135135DE00Q55459309-1997138D-B8F7-4669-BA68-A5F0C4F6BD2C
P2860
Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Impact of chromosome 1p status ...... zolomide: preliminary results.
@en
Impact of chromosome 1p status ...... zolomide: preliminary results.
@nl
type
label
Impact of chromosome 1p status ...... zolomide: preliminary results.
@en
Impact of chromosome 1p status ...... zolomide: preliminary results.
@nl
prefLabel
Impact of chromosome 1p status ...... zolomide: preliminary results.
@en
Impact of chromosome 1p status ...... zolomide: preliminary results.
@nl
P2093
P356
P1476
Impact of chromosome 1p status ...... zolomide: preliminary results.
@en
P2093
Ali Chahlavi
Andrew Kanner
David Peereboom
Gene Barnett
Paul Elson
Susan M Staugaitis
P2888
P304
P356
10.1023/A:1022580610598
P577
2003-02-01T00:00:00Z
P6179
1007951825